title: Pharmacogenomic-guided drug development: regulatory perspective.
authors: Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA. leskol@cder.fda.gov
authors: L J
authors: LJ
authors: Lesko
authors: J
authors: J
authors: Woodcock
mesh_terms: D002986:Clinical Trials as Topic; D015195:Drug Design; D004335:Drug and Narcotic Control; D023281:Genomics; D006801:Humans; D010597:Pharmacogenetics